Regen BioPharma Inc (RGBP)

[OTCShotCaller]

Review Of Developments Indicative of A Buy Out!

It appears there may be a Potential Merger Acquisition looming with Precigen OR another Big Pharma and if so it would make perfect sense for the following reasons.

The CEO of Precigen (PGEN) Helen Sabzevari is on RGBP's Scientific Advisory Board. PGEN trades on Nasdaq with a Market Cap of $1.3B and has an extensive clinical trials pipeline in Immunology-Oncology that includes development of mRNA vaccines therapies. https://precigen.com/about.

This company is in the same clinical therapeutic niche market of Oncology-Immunology candidate drug development that RGBP is in. 100% identical including the same mRNA vaccine technology so logically speaking it would make sense if PGEN straight up buys-out RGBP OR does a Merger Acquisition and IMO the motive to do this are the numerous valuable Patents RGBP owns that have Billion Dollar Market Capacity.

Now here's the other thing that I previously touch upon and will expand here if I may:

I strongly perceive the "hand writing is on the wall" for a Buy Out that logically could be with PGEN but if not, then a different Big Pharma, and here's a brief summary of why I suggest this:

Koos is presently on an aggressive campaign to pull everything together about RGBP in the shortest amount of time to apparently ready the company for SALE! If you look closely at his recent actions it points to this.

Let's objectively review what that is:

1). on 4/8/21 he files an 8K which in and of itself is a dead give-a-away of what he's up to. The question begs why would he file an 8K that specifically gives himself exclusive control of voting rights in negotiations for the sale of the company during the bidding process that's specifically intended to prevent a Hostile Take Over? And in doing this he states quote: “persons of interest who want to ACQUIRE RGBP must negotiate directly.” This is in reference to himself having sole control of voting rights that this 8K gives him. Other words, negotiations for sale of the company can't go around him to his board which is a typical move in any hostile take over. This by itself reveals what he's up to in addition to MANY other factors shown below. https://sec.report/Document/0001607062-21-000145/

2). he recently hired a Firm to get OTC current with FULL disclosure reporting. This has to do not only with SEC compliance to remain listed on the OTC beyond September 2021 but ALSO it provides transparency for any potential Big Pharma buyers that would never consider buying a company otherwise.

3). on 6/1/21 he files another 8K that has to do with resolving a lawsuit. This would be important to any potential buyers for reason a pending unresolved lawsuit would likely complicate negotiations of a buy out, or it would be a deterrent altogether. https://sec.report/Document/0001607062-21-000145/

4). we see him moving to get all his expired Patents updated. Logically this move would be consistent with preparing for an acquiring company to take over the patents then turn around and file an FDA IND post buy out in order to immediately place those candidate drug Patents in their clinical trials pipeline.

5). lastly he's not updating the company website that's been outdated for years. Why would he invested time, energy, and money in updating his company website if he's about to sell the company?

I believe these are all clear indicators of Koos moving in the direction of a Buy Out/Merger Acquisition.

This is ONLY an opinion but would appreciate feedback!

Thanks

Be well and prosper...